Queen Mary University Of London
Clinical trials sponsored by Queen Mary University Of London, explained in plain language.
-
Second chance: new trial aims to cure hepatitis c after first treatment fails
Disease control ENROLLING_BY_INVITATIONThis study is for people in Pakistan with hepatitis C whose first treatment didn't work. It compares two different medication plans to see which one clears the virus better. About 318 adults will take part, and the goal is to find a safe, effective second-line option.
Phase: NA • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated May 26, 2026 03:00 UTC
-
Could a short-course pill slow disability in advanced MS?
Disease control OngoingThis study tests whether cladribine tablets, given over two years, can protect hand function in people with advanced multiple sclerosis (MS). About 204 adults with significant disability (EDSS 6.5-8.5) will receive either cladribine or a placebo. The goal is to see if the drug sl…
Phase: PHASE2, PHASE3 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated May 26, 2026 03:00 UTC
-
Could a Three-Drug cocktail wipe out aggressive breast cancer before surgery?
Disease control OngoingThis study tests whether adding a drug called ipatasertib to standard chemotherapy and immunotherapy helps shrink or eliminate aggressive triple-negative breast tumors before surgery. About 146 women with newly diagnosed, high-risk breast cancer will participate. The main goal is…
Phase: PHASE2 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated May 26, 2026 02:57 UTC
-
Could a simple antimicrobial treatment save thousands of malnourished children?
Disease control OngoingThis study tests whether giving an antimicrobial treatment to children recovering from severe acute malnutrition can reduce their risk of death, re-hospitalization, or failure to regain healthy weight. About 674 children aged 6-59 months who are hospitalized with complicated maln…
Phase: PHASE3 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
Could a vitamin a derivative boost chemo for pancreatic cancer?
Disease control OngoingThis study tests whether adding a drug called ATRA (a form of vitamin A) to standard chemotherapy can help people with locally advanced pancreatic cancer live longer without their disease getting worse. About 170 participants will receive either chemo alone or chemo plus ATRA. Th…
Phase: PHASE2 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated May 20, 2026 12:01 UTC
-
New stent valve offers hope for rare heart condition patients unable to have surgery
Disease control OngoingThis study tests a new stent valve (TRICENTO) in 15 people with carcinoid heart disease who have a severely leaky tricuspid valve and cannot have open-heart surgery. The goal is to see if the implant can reduce the leak and improve symptoms and quality of life. Participants will …
Phase: NA • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
Could a simple blood test finally spot hidden TB?
Diagnosis ENROLLING_BY_INVITATIONThis study is testing a new blood test that looks for the TB bacteria itself, rather than the body's immune response. Current tests can't tell if treatment for dormant TB worked, or who will get sick later. Researchers will test 100 people with and without dormant TB to see if th…
Sponsor: Queen Mary University of London • Aim: Diagnosis
Last updated May 26, 2026 02:55 UTC
-
New urine test could spot deadly pancreatic cancer sooner
Diagnosis OngoingThis study is working on a new way to detect pancreatic cancer earlier using a simple urine or blood test. Researchers are collecting samples from 3500 people with and without pancreatic disease to see if a panel of biomarkers can accurately identify cancer. The goal is to create…
Sponsor: Queen Mary University of London • Aim: Diagnosis
Last updated May 22, 2026 14:05 UTC
-
New DNA blood test could slash diagnosis time for deadly heart infection
Diagnosis OngoingThis study looks at a new blood test that uses DNA sequencing to quickly identify the bacteria causing infective endocarditis, a serious heart infection. Current methods take up to 5 days to grow bacteria from blood samples, delaying the right treatment. The new test aims to give…
Sponsor: Queen Mary University of London • Aim: Diagnosis
Last updated May 18, 2026 12:01 UTC
-
Massive study reveals clues to prostate Cancer's future
Knowledge-focused OngoingThis study looked back at 3350 men with early-stage prostate cancer who chose watchful waiting instead of immediate treatment. Researchers analyzed medical records and biopsy samples to find which factors, like PSA levels and Gleason scores, best predict how the disease will prog…
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated May 26, 2026 03:01 UTC
-
Can a blister test help solve ARDS? new study explores Drug's effect on fluid leak
Knowledge-focused OngoingThis study looks at whether a drug called Racecadotril can reduce fluid leakage in skin blisters caused by a chemical. The blisters mimic some aspects of lung injury in ARDS, a severe condition where lungs fill with fluid. 48 healthy volunteers will receive either the drug or a p…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated May 26, 2026 02:57 UTC
-
New patch could replace needles for monitoring heart surgery patients
Knowledge-focused OngoingThis study tests a wearable sensor that measures lactate levels through the skin, comparing it to standard blood tests in 20 patients recovering from heart bypass or valve surgery. The goal is to see if the sensor can reduce the need for frequent blood draws and provide more comf…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated May 22, 2026 14:05 UTC
-
Thai health revolution: Data-Driven system aims to tame chronic disease crisis
Knowledge-focused OngoingThis study tests a new way of organizing care for chronic diseases like high blood pressure, diabetes, and kidney disease in Thailand. Researchers will work with 16 primary care clinics to see if using patient data in real time helps doctors and nurses provide better care. The go…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated May 22, 2026 13:53 UTC
-
AI reads skin cancer slides to forecast patient futures
Knowledge-focused OngoingThis study tests whether a computer model can look at images of skin cancer tissue and predict how the disease will progress. Researchers will analyze samples from 300 patients with a type of skin cancer called squamous cell carcinoma. The goal is to see if the AI can spot which …
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC
-
Transgender HPV screening study seeks better testing options
Knowledge-focused OngoingThis study looks at how common high-risk HPV is in transgender people and whether self-collected samples (from the vagina, anus, urine, or mouth) work as well as clinician-collected ones. About 100 transgender men and women will take their own samples and answer a survey about co…
Phase: NA • Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated May 18, 2026 12:04 UTC